Alcohol-related liver disease is the most prevalent type of chronic liver disease worldwide,
accounting for 30% of hepatocellular carcinoma (HCC) cases and HCC-specific deaths …

Background and Aims Hepatocellular carcinoma (HCC) surveillance is associated with early
tumor detection and improved survival; however, it is often underused in clinical practice. We …

Background Surveillance for hepatocellular carcinoma (HCC) has level I evidence among
patients with hepatitis B but only level II evidence in patients with cirrhosis. This lack of …

Importance Deep learning, a family of machine learning models that use artificial neural
networks, has achieved great success at predicting outcomes in nonmedical domains …

Although surveillance ultrasound and alpha fetoprotein (AFP) tests have minimal direct
harm, downstream harms from follow‐up tests must be weighed against surveillance …

Background & Aims Hepatocellular carcinoma (HCC) risk varies dramatically in patients with
cirrhosis according to well-described, readily available predictors. We aimed to develop …

The prognosis of untreated patients with hepatocellular carcinoma (HCC) is heterogeneous,
and survival data were mainly obtained from control arms of randomized studies. Clinical …

Unlike most solid tumors, the incidence and mortality of hepatocellular carcinoma (HCC)
have increased in the United States and Europe in the past decade. Most patients are …

Hepatocellular carcinoma (HCC) is a common malignancy in developing countries and its
incidence is on the rise in the developing world. The epidemiology of this cancer is unique …

Aim: Worldwide, hepatocellular cancer (HCC) is the fourth leading cause of cancer death
and occurs 3 times more commonly in males than females. Current surveillance practices do …